MUC1 and interstitial lung disease: Ultimately, we ought to determine whether KL-6 could be a marker of disease severity and bad prognosis.<h4>Results</h4>Our results showed that serum KL-6 levels in COVID-19 patients were increased compared to healthy subjects, but to a lesser extent than in patients suffering from ILD.